A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID)

Malchair, Pierre; Otero, Aurema; Giol, Jordi; Solanich, Xavier; Carnaval, Thiago; Fernández-Nistal, Alonso; Sánchez-Gabriel, Ana; Montoto, Carmen; Lleonart, Ramon; Videla, Sebastián

doi:10.1186/s13063-022-06219-7

Trials

Article metrics
Last updated: Wed, 24 Apr 2024 22:06:10 Z

A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID)

Access & Citations

1880

Article Accesses
5

Web of Science
5

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1745-6215

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com